Jump to content

Emily_N

Members
  • Posts

    9
  • Joined

  • Last visited

Profile Information

  • City
    Brooklyn
  • US State (if applicable)
    NEW YORK
  • Country
    USA
  • Status
    Not a patient

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

  1. Thanks so much Judy! I am in this group! It also helped a lot with some of my initial questions and seeing people's responses with exon 19 and 21. A lifesaver.
  2. Hi All! Just wanted to give an update that my Mom had her first CAT scan post starting Tagrisso and has an 80% reduction in the size of the tumor and no more liquid surrounding her lung. I know this will be an ongoing journey but I'm hoping the Tag can give us a few more good years. She is responding well to it and is still on 80mg with minimal side effects so we're both very happy!
  3. That is how we are feeling. The doctor honestly wasn't pushing it. I think as a cancer center they just make it an option to anyone who falls within the studies parameters. The phase 2 trial out of Japan had slightly positive results for people who were smokers but otherwise didn't seem to show much improvement and obviously, there are adverse side effects that come up with a handful of patients. Just didn't want to foreclose any option that could be good.
  4. Hi Everyone! I am a caregiver. My Mom just got her biomarker results back yesterday and she has the EGFR exon 21 mutation. She is 75 and a former smoker, stage 4a (only saying this as it may be relevant regarding clinical trials). Her doctor gave her treatment options of either starting tagrisso alone or signing up for a clinical trial to see if taking tagrisso with avastin extends recurrence. she's leaning towards only doing tag given the difference in treatment requirements and possible side effects but wondered if people who had been following this for a longer time had any experiences or updates? I saw a thread discussing this trial from back in May 21 but didn't see any updates since then.
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.